Drugs that contain Histrelin Acetate
1. Supprelin La patents expiration
SUPPRELIN LA's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8062652 | ENDO PHARM | Compositions and methods for treating precocious puberty |
Jun, 2026
(2 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | May 03, 2014 |
Market Authorisation Date: 03 May, 2007
Treatment: Method of treatment of children with central precocious puberty
Dosage: IMPLANT;SUBCUTANEOUS
More Information on Dosage
SUPPRELIN LA family patents
